ClearPoint Neuro Announces Agreement to Acquire IRRAS
Accessnewswire· 2025-11-07 05:50
Acquisition Will Further Expand the Potential of ClearPoint Neuro's Drug Delivery Portfolio While Immediately Adding New Indications and Commercial Scale Across a $0.5 Billion Market for the Treatment of Intracranial Bleeding SOLANA BEACH, CALIFORNIA / ACCESS Newswire / November 6, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced the acquisition of San Diego based, IRRAS H ...
Affirm Q1 2026 Earnings Call - Buy Now, Sell Later?
Forbes· 2025-11-07 05:50
Max Levchin, CEO of Affirm (Pictured). Fed rate cuts and clearer U.S. credit guidance ease funding pressure and boost outlooks for BNPL players like Affirm.Getty ImagesThe Buy Now, Pay Later (BNPL) industry is at a pivotal moment as its largest U.S. pure-play, Affirm (AFRM), prepares to report fiscal first-quarter 2026 earnings today after the market close. Many investors are wondering whether this is the right time to buy or sell.Affirm reports fiscal Q1 2026 results today, covering July through September ...
美议员要求英国王之弟安德鲁就爱泼斯坦案接受问询
央视新闻· 2025-11-07 05:49
这封由16名民主党议员联署的信件,要求安德鲁以"笔录面谈"的形式,就爱泼斯坦案回答相关问题,以 配合美国国会众议院监督委员会的调查。信中指出,安德鲁"与爱泼斯坦长期保持密切关系",且相关指 控"有充分记录",因此"可能掌握关于共谋者和协助者的重要信息"。议员们表示,安德鲁的证词将有助 于厘清爱泼斯坦在美国及海外的性交易网络。 当地时间11月6日获悉,美国国会民主党人正式致函英国国王查尔斯三世的弟弟安德鲁,要求其就爱泼 斯坦相关案件接受问询。 (文章来源:央视新闻) 据悉,美国国会众议院监督委员会并无权力强制安德鲁出面作证。目前,该委员会由共和党人掌控,他 们是否支持这一要求尚未可知。 美国富商爱泼斯坦生前与不少政商名流交往密切,因涉嫌性犯罪被捕后,于2019年8月死于狱中,被认 定为"自杀",但这一结论受到不同政治群体的质疑。安德鲁被指认与爱泼斯坦关系匪浅,曾在爱泼斯坦 名下豪宅与未成年女性发生性关系。但这类说法遭安德鲁否认。而关键证人及受害者之一的弗吉尼娅· 朱弗雷已于今年4月自杀身亡。安德鲁的丑闻持续冲击英国王室声誉。英国国王查尔斯三世已宣布剥夺 安德鲁的尊号、头衔和荣誉,并通知其搬离王室住所。 ...
Strong likelihood S&P 500 moves toward 6,500, says BTIG's Jonathan Krinsky
Youtube· 2025-11-07 05:49
As we head toward the close, we do want to bring in BTI's Jonathan Kinsky. Uh Jonathan, thank you so much for joining us here today. Obviously, we've had a lot of discussion about how AI is driving things lower today.You're looking at the 50-day moving average. What's so important about what you're seeing right now. >> Hey, Courtney.So, yeah, it's been a remarkable streak. We we have not touched the 50-day moving average in 145 trading days. That's the third longest streak since 1990. The second longest str ...
Settling and repricing of AI stocks is important, says Farr, Miller & Washington's Michael Farr
Youtube· 2025-11-07 05:48
Well, all four major averages back in the red after yesterday's bounce. Tech once again the lagard as some recent highf flyers return to earth. Should investors view any pullback as a buying opportunity.Far Miller and Washington President CEO Michael Farre joins us. Michael, good to see you. Um, some of the highest valuation stocks in the market are also the biggest in tech.And so even beneath the index level, I wonder is there anywhere to hide. Won't the whole market get dragged down if there's a sentiment ...
Eli Lilly expects US FDA approval for oral obesity drug in March 2026
Reuters· 2025-11-07 05:48
Eli Lilly expects the U.S. Food and Drug Administration to approve its experimental oral obesity drug, orforglipron, by March 2026, its chief executive said on Thursday. ...
Affirm Stock Rallies After Q1 Earnings Report: Here's Why
Benzinga· 2025-11-07 05:48
Affirm Holdings, Inc. (NASDAQ:AFRM) shares rallied after the company released its first-quarter earnings report after Thursday's closing bell, beating analyst estimates. Here's a look at the details in the report. AFRM stock is moving. See the real-time price action here.The Details: Affirm Holdings reported quarterly earnings of 23 cents per share, which beat the consensus estimate of 11 cents.Quarterly revenue came in at $933.33 million, which beat the Street estimate of $883.14 million and was up from re ...
Expedia shares pop more than 9% on quarterly beat
Youtube· 2025-11-07 05:48
Our Expedia earnings are out and the company's reporting EPS of $757 versus estimates of 692. Revenue also beating coming in at $4.1% billion versus estimates of $4.28% billion. I think there's a number off there.Booked room nights coming in at 108 million versus estimates of $103.87% million. And the company sees fourth quarter revenue growth of 6 to 8% versus estimates of 2.7%. You can see shares of Expedia are taking off right now.They're up almost 9%. So, Michael Farre, if I go back to you for response ...
IREN Reports Record FY26 Q1 Profitability
247Wallst· 2025-11-07 05:47
IREN Ltd. (NASDAQ: IREN) reported Q1 FY26 earnings after market close on Nov. ...